NOVO Stock Chart & Stats
C$19.66
-C$0.42(-2.10%)
At close: 4:00 PM EDT
C$19.66
-C$0.42(-2.10%)
Day’s Range― - ―
52-Week RangeC$14.88 - C$27.58
Previous CloseN/A
Volume27.43K
Average Volume (3M)27.59K
Market Cap
C$284.12B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.28%
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,390,128,000
10 Day Avg. Volume9,470
30 Day Avg. Volume27,587
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged News
NOVO FAQ
What was Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s price range in the past 12 months?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged lowest stock price was C$14.88 and its highest was C$27.58 in the past 12 months.
What is Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s market cap?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s market cap is C$284.12B.
When is Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s upcoming earnings report date?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s upcoming earnings report date is Nov 04, 2026 which is in 55 days.
How were Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s earnings last quarter?
Currently, no data Available
Is Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged overvalued?
According to Wall Street analysts Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s price is currently Overvalued.
Does Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged pay dividends?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged pays a Notavailable dividend of C$0.244 which represents an annual dividend yield of 3.28%. See more information on Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged dividends here
What is Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s EPS estimate?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged have?
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged has 3,390,128,000 shares outstanding.
What happened to Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged?
Currently, no hedge funds are holding shares in TSE:NOVO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged Stock Smart Score
Company Description
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged (NOVO) Earnings & Revenues
Technical Analysis
Roche Holding Ltd CAD Hedged CIBC CDR
―
Novartis AG CAD Hedged CIBC CDR
―
Sanofi SA Unsponsored CDR Hedged Reg S
―
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
―
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―